Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 70


The mononuclear phagocyte system in organ transplantation.

Ochando J, Kwan WH, Ginhoux F, Hutchinson JA, Hashimoto D, Collin M.

Am J Transplant. 2015 Nov 25. doi: 10.1111/ajt.13627. [Epub ahead of print]


Risk factors and natural history of breast cancer in younger Chinese women.

Yeo W, Lee HM, Chan A, Chan EY, Chan MC, Chan KW, Chan SW, Cheung FY, Cheung PS, Choi PH, Chor JS, Foo WW, Kwan WH, Law SC, Li LP, Tsang JW, Tung Y, Wong LL, Wong TT, Yau CC, Yau TK, Zee BC.

World J Clin Oncol. 2014 Dec 10;5(5):1097-106. doi: 10.5306/wjco.v5.i5.1097.


Initial experience with the Oncotype DX assay in decision-making for adjuvant therapy of early oestrogen receptor-positive breast cancer in Hong Kong.

Cheung PS, Tong AC, Leung RC, Kwan WH, Yau TC.

Hong Kong Med J. 2014 Oct;20(5):401-6. doi: 10.12809/hkmj134140. Epub 2014 Jun 20.


Male breast cancer: a population-based comparison with female breast cancer in Hong Kong, Southern China: 1997-2006.

Kwong A, Chau WW, Mang OW, Wong CH, Suen DT, Leung R, Wong K, Lee A, Shea C, Morse E; Hong Kong Breast Cancer Research Group, Law SC.

Ann Surg Oncol. 2014 Apr;21(4):1246-53. doi: 10.1245/s10434-013-3377-8. Epub 2013 Dec 12.


Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells.

van der Touw W, Cravedi P, Kwan WH, Paz-Artal E, Merad M, Heeger PS.

J Immunol. 2013 Jun 15;190(12):5921-5. doi: 10.4049/jimmunol.1300847. Epub 2013 May 20.


Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.

Kwan WH, van der Touw W, Paz-Artal E, Li MO, Heeger PS.

J Exp Med. 2013 Feb 11;210(2):257-68. doi: 10.1084/jem.20121525. Epub 2013 Feb 4.


Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.


Antigen-presenting cell-derived complement modulates graft-versus-host disease.

Kwan WH, Hashimoto D, Paz-Artal E, Ostrow K, Greter M, Raedler H, Medof ME, Merad M, Heeger PS.

J Clin Invest. 2012 Jun;122(6):2234-8. doi: 10.1172/JCI61019. Epub 2012 May 15.


Complement regulation of T cell immunity.

Kwan WH, van der Touw W, Heeger PS.

Immunol Res. 2012 Dec;54(1-3):247-53. doi: 10.1007/s12026-012-8327-1. Review.


Early data from the first population-wide breast cancer-specific registry in Hong Kong.

Cheung P, Hung WK, Cheung C, Chan A, Wong TT, Li L, Chan SW, Chan KW, Choi P, Kwan WH, Yau CC, Chan EY, Law SC, Kwan D.

World J Surg. 2012 Apr;36(4):723-9. doi: 10.1007/s00268-012-1426-2.


Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.

Vieyra M, Leisman S, Raedler H, Kwan WH, Yang M, Strainic MG, Medof ME, Heeger PS.

Am J Pathol. 2011 Aug;179(2):766-74. doi: 10.1016/j.ajpath.2011.04.038. Epub 2011 Jun 23.


Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.

Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, Leboeuf M, Ginhoux F, Ochando JC, Kunisaki Y, van Rooijen N, Liu C, Teshima T, Heeger PS, Stanley ER, Frenette PS, Merad M.

J Exp Med. 2011 May 9;208(5):1069-82. doi: 10.1084/jem.20101709. Epub 2011 May 2.


Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.

Bienaime F, Dragon-Durey MA, Regnier CH, Nilsson SC, Kwan WH, Blouin J, Jablonski M, Renault N, Rameix-Welti MA, Loirat C, Sautés-Fridman C, Villoutreix BO, Blom AM, Fremeaux-Bacchi V.

Kidney Int. 2010 Feb;77(4):339-49. doi: 10.1038/ki.2009.472. Epub 2009 Dec 16.


A broadly adaptive array of dose-constraint templates for planning of intensity-modulated radiation therapy for advanced T-stage nasopharyngeal carcinoma.

Chau RM, Leung SF, Kam MK, Cheung KY, Kwan WH, Yu KH, Chiu KW, Cheung ML, Chan AT.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):21-8. doi: 10.1016/j.ijrobp.2008.07.041. Epub 2009 Jan 24.


Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.

Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK, Yu BK, Chiu SK, Kwan WH, Ho R, Chan I, Ahuja AT, Zee BC, Chan AT.

J Clin Oncol. 2009 Jan 10;27(2):242-9. doi: 10.1200/JCO.2008.18.1545. Epub 2008 Dec 8.


Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.

Mak SS, Yeo W, Lee YM, Mo KF, Tse KY, Tse SM, Ho FP, Kwan WH.

Nurs Res. 2008 Nov-Dec;57(6):416-25. doi: 10.1097/NNR.0b013e31818c3de2.


Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth.

Kwan WH, Navarro-Sanchez E, Dumortier H, Decossas M, Vachon H, dos Santos FB, Fridman HW, Rey FA, Harris E, Despres P, Mueller CG.

PLoS Negl Trop Dis. 2008 Oct 1;2(10):e311. doi: 10.1371/journal.pntd.0000311.


Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection.

Pavlov V, Raedler H, Yuan S, Leisman S, Kwan WH, Lalli PN, Medof ME, Heeger PS.

J Immunol. 2008 Oct 1;181(7):4580-9.


A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.

Yeo W, Mo FK, Suen JJ, Ho WM, Chan SL, Lau W, Koh J, Yeung WK, Kwan WH, Lee KK, Mok TS, Poon AN, Lam KC, Hui EK, Zee B.

Breast Cancer Res Treat. 2009 Feb;113(3):529-35. doi: 10.1007/s10549-008-9957-9. Epub 2008 Mar 10.


A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.

Chau RM, Leung SF, Kam MK, Cheung KY, Kwan WH, Yu KH, Chiu SK, Chan AT.

Clin Oncol (R Coll Radiol). 2008 Mar;20(2):134-41. Epub 2007 Nov 26.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk